Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education

Under Oral Anticoagulation Patients Clinical Trial

— EDUCONSULT  

Official title:

Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education of Patients on Anticoagulants During a Routine Inspection by the Cardiologist.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02907151
• Other study ID #: RECHMPL16_0275
• Status: Completed
• Start date: September 2016
• Est. completion date: March 2017

Study information

• Verified date: September 2016
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To assess the value of a dedicated knowledge questionnaire, filled by the patient prior consultation. Indeed, it could allow to target specific shortcomings of patients first, and help the cardiologist to prioritize the other therapeutic education, targeting specifically the information provided.

Description:

The main objective is to study the impact of a pre-consultation questionnaire on the knowledge gained by the patient on anticoagulant treatment at the exit of cardiology consultation.

The assumption is that this questionnaire would help educate patients about their shortcomings and educate cardiologists lack of knowledge of his patient.

The secondary objectives are :

• Target specific areas in which patients have the greatest lack of information

• Assess the impact of educational level on information

• Assess the impact of age on information

• Evaluate the satisfaction of the information delivered

• Assess patient anxiety vis-à-vis their treatment

• Evaluate the failure rate of the questionnaire to know the number of patients refusing to participate in the study

Recruitment information / eligibility

• Status: Completed
• Enrollment: 160
• Est. completion date: March 2017
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Patient monitoring Cardiology Consultation at University Hospital of Montpellier, whatever the reason

• Patients on oral anticoagulant therapy (warfarin or AOD) for over a month.

Exclusion Criteria:

• Severe cognitive disorders, making it impossible to understand the patient on therapeutic education.

• Disorders of the important vision.

Related Conditions & MeSH terms

• Under Oral Anticoagulation Patients

Intervention

Other:
• Survey
Complete a survey prior to the consultation and a questionnaire after

Locations

Country	Name	City	State
France	Leclercq	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of correct answers	score (number of correct answers) to the survey	3 months
Secondary	Score information	Score information for the different areas of the survey	3 months
Secondary	Score on the provision of additional information	Score on the provision of additional information in the consultation.	3 months
Secondary	anxiety score	anxiety score by a self-evaluation of the patient.	3 months
Secondary	Score information based on subgroups	Score information based on subgroups: level of education; Age; Sex	3 months